FDA Approval: The FDA granted full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid ...
The high-stakes nature of cancer care, coupled with rapid scientific advancements, increasing payer and regulatory pressures, ...
Lancaster University researchers are driving forward a project to improve online support for stroke and neurology patients across the region.The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback